Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Aug;46(2):95-9.
doi: 10.1046/j.1365-2125.1998.00770.x.

Best practice in therapeutic drug monitoring

Affiliations
Review

Best practice in therapeutic drug monitoring

A S Gross. Br J Clin Pharmacol. 1998 Aug.

Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pharmacokinetics and pharmacodynamics contribute to variability in the relationship between drug dose and response.

Comment in

Similar articles

Cited by

References

    1. Levy G, Ebling WF, Forrest A. Concentration- or effect-controlled clinical trials with sparse data. Clin Pharmacol Ther. 1994;56:1–8. - PubMed
    1. Campbell M. Community-based therapeutic drug monitoring. Clin Pharmacokinet. 1995;28:271–274. - PubMed
    1. Aronson JK, Hardman M. Measuring plasma drug concentrations. Br Med J. 1992;305:1078–1080. - PMC - PubMed
    1. Birkett DJ. Therapeutic drug monitoring. Australian Prescriber. 1997;20:9–11.
    1. Spector R, Park GD, Johnson G, et al. Therapeutic drug monitoring. Clin Pharmacol Ther. 1988;43:345–353. - PubMed

MeSH terms